1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1 Drivers
4.1.1 Inclination of pharmaceutical companies to switch from Rx to OTC drugs
4.1.2 Favorable regulatory framework
4.1.3 Immense cost savings
4.1.4 High Penetration in emerging markets
4.1.5 Product Innovation
4.2 Restraints
4.2.1 Incorrect self-diagnosis
4.2.2 Lack of awareness among the rural regions
4.2.3 Probability of substance abuse
4.3 Opportunities
4.3.1 Increasing Need for Over-the-Counter Drugs
4.4 Challenges
4.4.1 Lack of valid literature
4.4.2 High expenditure on advertisements
4.4.3 Counterfeit drugs
5. South America Over-the-Counter (OTC) Drugs Market - By Product Category
5.1 Cough and Cold
5.2 Analgesics
5.3 Vitamin, Minerals, and Supplements
5.4 Dermatological Products
5.5 Gastrointestinal Products
5.6 eight Loss/Dietary Products
5.7 Ophthalmic Products
5.8 Sleep Aids
5.9 Smoking Cessation Aids
5.10 Others
6. South America Over-the-Counter (OTC) Drugs Market - By Country
6.1. Introduction
6.2. Brazil
6.3. Argentina
6.4. Rest of South America
7. Company Profiles
7.1 Bayer Health Care
7.1.1. Company Overview
7.1.2. Business Segments
7.1.3. Financial Performance (Public Enterprises)
7.1.4. SWOT Analysis
7.2. GlaxoSmithKline
7.3 Sanofi
7.4 Johnson & Johnson
7.5 Pfizer
7.6 Sun Pharmaceuticals Industries Ltd.
7.7 Alkem Laboratories Limited
7.8 Cipla, Inc.
7.9 Teva Pharmaceutical Industries Ltd.
7.10 Glenmark Pharmaceuticals Ltd.
7.11 Takeda
7.12 Innovus Pharmaceutical Inc.
7.13 Dr. Reddy's Laboratories
7.14 Reckitt Benckiser Group Plc
7.15 Piramal
8. South America Over-the-Counter (OTC) Drugs Market - Competitive Landscape
8.1 Market Share Analysis
8.2 Strategies Adopted by top companies
8.3 Mergers, Acquisitions, Collaborations & Agreements
9. Market Insights
9.1 Insights of Industry Experts
9.2 Investment Opportunities
9.3 Analyst Opinion
10. Appendix
10.1 List of Tables
10.2 List of Figures
